These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1090157)

  • 1. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas.
    Morris MW; Davey FR
    Am J Clin Pathol; 1975 Mar; 63(3):403-14. PubMed ID: 46698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and morphologic studies of T cell lymphoma.
    Mann RB; Jaffe ES; Braylan RC; Eggleston JC; Ransom L; Kaizer H; Berard CW
    Am J Med; 1975 Mar; 58(3):307-13. PubMed ID: 1078753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosette-forming lymphocytes in normals and patients with malignant lymphomas.
    Cohnen G; Augener W; Buka A; Brittinger G
    Acta Haematol; 1974; 51(2):65-75. PubMed ID: 4217078
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia.
    Hsu CC; Marti GE; Schrek R; Williams RC
    Clin Immunol Immunopathol; 1975 Jan; 3(3):385-95. PubMed ID: 803233
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphosarcoma cell leukemia: the contribution of cell surface study to diagnosis.
    Aisenberg AC; Wilkes B
    Blood; 1976 Nov; 48(5):707-15. PubMed ID: 788814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of two lymphomas with distinctive histologic, ultrastructural, and immunologic features.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Clin Pathol; 1978 Sep; 70(3):409-15. PubMed ID: 360821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T and B cell populations in blood and lymph node in lymphoproliferative disease.
    Cooper DA; Petts V; Luckhurst E; Biggs JC; Penny R
    Br J Cancer; 1975 May; 31(5):550-8. PubMed ID: 1080424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
    Sundström C; Nilsson K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.